Abstract：
BACKGROUND:The Patient Protection and Affordable Care Act instituted pay-for-performance programs, including Hospital Value-Based Purchasing (HVBP), designed to encourage hospital quality and efficiency. OBJECTIVE AND METHOD:While these programs have been evaluated with respect to their implications for care quality and financial viability, this is the first study to assess the relationship between hospitals' cost inefficiency and their participation in the programs. We estimate a translog specification of a stochastic cost frontier with controls for participation in the HVBP program and clinical and outcome quality for California hospitals for 2012-2015. RESULTS:The program-participation indicators' parameters imply that participants were more cost inefficient than their peers. Further, the estimated coefficients for summary process of care quality indexes for three health conditions (acute myocardial infarction, pneumonia, and heart failure) suggest that higher quality scores are associated with increased operating costs. CONCLUSION:The estimated coefficients for the outcome quality variables suggest that future determination of HVBP payment adjustments, which will depend solely on mortality rates as measures of clinical care quality, may not only be aligned with increasing healthcare quality but also reducing healthcare costs.
journal_name
Appl Health Econ Health Policyjournal_title
Applied health economics and health policyauthors
Izón GM,Pardini CAdoi
10.1007/s40258-017-0357-3subject
Has Abstractpub_date
2018-02-01 00:00:00pages
79-90issue
1eissn
1175-5652issn
1179-1896pii
10.1007/s40258-017-0357-3journal_volume
16pub_type
杂志文章abstract：BACKGROUND:Antiplatelet therapy plays a central role in the prevention of atherothrombotic events. Both acetylsalicylic acid (aspirin) and clopidogrel have been shown to reduce the risk of recurrent cardiovascular events in various subgroups of patients with vascular disease. OBJECTIVE:To estimate the cost effectivene...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/11535520-000000000-00000
更新日期：2010-01-01 00:00:00
abstract：BACKGROUND:There is limited understanding of the health economic implications of cervical screening with human papillomavirus (HPV)-16/18 genotyping. OBJECTIVE:The aim of this study was to evaluate the cost effectiveness of cervical cancer primary screening with a HPV-16/18 genotyping test which simultaneously detects...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-014-0135-4
更新日期：2015-02-01 00:00:00
abstract：BACKGROUND:Total hip replacement (THR) must be managed in a more sustainable manner. More cost-effective surgical techniques and the centralization/regionalization of services are two solutions. The former requires an assessment of newer minimally invasive and muscle-sparing surgical techniques. The latter necessitates...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-016-0260-3
更新日期：2016-12-01 00:00:00
abstract：OBJECTIVE:Compared to traditional drugs, specialty drugs tend to be indicated for lower prevalence diseases. Our objective was to compare the potential population health benefits associated with specialty and traditional drugs in the year following product approval. METHODS:First, we created a dataset of estimates of ...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-016-0291-9
更新日期：2017-04-01 00:00:00
abstract：:One focus of health economics is the trade-off between limited resources and the (health) needs of a community. Cost-effectiveness analysis (CEA), while being one of the most accepted evaluation methodologies in health economics, does not account for many important costs and benefits of health care interventions. Some...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：
更新日期：2003-01-01 00:00:00
abstract：:Healthcare reforms aim to change certain parts of the health system to improve quality of care, access, or financial sustainability. Traditionally, healthcare reform is understood as an action undertaken by a government at a national or local level. However, bottom-up changes can also lead to improvements in the healt...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-017-0315-0
更新日期：2017-12-01 00:00:00
abstract：BACKGROUND:It is estimated that annually 300 000 cases of rotavirus-induced gastroenteritis (RVGE) occur in children aged up to 5 years in France. A two-dose vaccine against rotavirus infection (RIX4414; Rotarix, GlaxoSmithKline), has been shown to be highly effective against severe RVGE. OBJECTIVE:This study evaluate...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/BF03256134
更新日期：2008-01-01 00:00:00
abstract：BACKGROUND:Low back pain (LBP) is a major health problem, having a substantial effect on peoples' quality of life and placing a significant economic burden on healthcare systems and, more broadly, societies. Many interventions to alleviate LBP are available but their cost effectiveness is unclear. OBJECTIVES:To identi...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-016-0268-8
更新日期：2017-04-01 00:00:00
abstract：BACKGROUND:Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low sensitivity for identifying subjects at risk of VTE. Thrombo inCode(®) is a new genetic tool that has demonstrated very good sensitivity, thanks to very good cov...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-015-0153-x
更新日期：2015-04-01 00:00:00
abstract：:The Peristeen transanal irrigation system is intended to allow people with bowel dysfunction to flush out the lower part of the bowel as part of their bowel management strategy. Peristeen was the subject of an evaluation by the National Institute for Health and Care Excellence, through its Medical Technologies Evaluat...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-018-0447-x
更新日期：2019-02-01 00:00:00
abstract：BACKGROUND:Employers are increasingly relying on rewards programmes in an effort to promote greater levels of activity among employees; however, if enrolment in these programmes is dominated by active employees, then they are unlikely to be a good use of resources. OBJECTIVE:This study uses a stated-preference survey ...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-017-0327-9
更新日期：2017-10-01 00:00:00
abstract：:The rapid rise in pharmaceutical costs in France has been driven by new technologies and the growing prevalence of chronic diseases as well as considerable prescribing freedom and choice of physician among patients. This has led to the introduction of a number of reforms and initiatives in an attempt to moderate expen...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/BF03256162
更新日期：2010-01-01 00:00:00
abstract：BACKGROUND:As tuberculosis screening trends to targeting high-risk populations, knowing the cost effectiveness of such screening is vital to decision makers. OBJECTIVES:The purpose of this review was to compile cost-utility analyses evaluating latent tuberculosis infection (LTBI) screening in high-risk populations tha...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-015-0183-4
更新日期：2015-08-01 00:00:00
abstract：BACKGROUND:Although the costs of treating inflammatory bowel disease (IBD) in developed countries are well established, they remain largely unknown in countries with recent histories of socio-economic transition including Serbia. OBJECTIVE:To estimate the costs of treatment including the resources used by patients wit...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-016-0272-z
更新日期：2017-02-01 00:00:00
abstract：BACKGROUND:In virologically suppressed patients, switching to darunavir/ritonavir (DRV/r) monotherapy maintains HIV RNA suppression, and could also lower treatment costs. OBJECTIVE:The purpose of this analysis was to calculate the potential cost savings from the use of DRV/r monotherapy in the UK. METHODS:In the MONE...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,随机对照试验
doi：10.2165/11592220-000000000-00000
更新日期：2011-07-01 00:00:00
abstract：:This paper reconsiders the evidence and several of the key arguments associated with the theory of supplier-induced demand (SID). It proposes a new theory to explain how ethical behaviour is consistent with SID. The purpose of a theory of demand and one criterion for the evaluation of a theory is the provision of a pl...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.2165/00148365-200605020-00003
更新日期：2006-01-01 00:00:00
abstract：BACKGROUND AND OBJECTIVE:Opinions on the use of research abstracts in policy decision making are conflicting. We sought to evaluate the influence of research abstracts in guiding decisions of the Joint Oncology Drug Review of Canada (JODR), which conducts clinical and economic reviews of new cancer treatment drugs for ...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/11530510-000000000-00000
更新日期：2010-01-01 00:00:00
abstract：AIM:To assess the relative cost effectiveness of four strategies (academic detailing, computerised reminder systems, target payments and interactive continuing medical education) to increase the provision of screening and brief interventions by Australian GPs with the ultimate goal of decreasing risky alcohol consumpti...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.2165/00148365-200605030-00002
更新日期：2006-01-01 00:00:00
abstract：:The biotech industry now accounts for a substantial and growing proportion of total R&D spending on new medicines. However, compared with the pharmaceutical industry, the biotech industry is financially fragile. This article illustrates the financial fragility of the biotech and pharmaceutical industries in the US and...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/BF03256149
更新日期：2009-01-01 00:00:00
abstract：:The first objective of this paper is to expound the particular challenge posed by the occurrence of inconsistency in the expression of preferences by mental health patients to both economists and policy makers. Since this difficulty cannot be resolved, the second aim of the paper is to identify agents who may be count...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-019-00479-2
更新日期：2020-04-01 00:00:00
abstract：:The aim of the review is to establish whether, on the basis of previous published evidence, current accepted guidance for health economic evaluation needs to be adapted to evaluate healthcare based on use of genetic information. Online literature search strategies were designed (using PubMed and the NHS Economic Evalu...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.2165/00148365-200605010-00004
更新日期：2006-01-01 00:00:00
abstract：OBJECTIVES:To analyse the cost effectiveness of community-based case management for patients suffering from chronic obstructive pulmonary disease (COPD). METHODS:The study took place in the third largest municipality in Denmark and was conducted as a randomised controlled trial with 12 months of follow-up. A total of ...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-016-0298-2
更新日期：2017-06-01 00:00:00
abstract：OBJECTIVES:The objective of the present work was to assess the level of evidence in economic evaluations of percutaneous left atrial appendage closure devices, and to test the complementarity of three different tools for assessing the quality of economic evaluations. METHODS:We conducted a systematic review of article...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-018-0429-z
更新日期：2018-12-01 00:00:00
abstract：OBJECTIVES:The objective of this study was to construct an early economic evaluation for acalabrutinib for relapsed chronic lymphocytic leukaemia (CLL) to assist early reimbursement decision making. Scenarios were assessed to find the relative impact of critical parameters on incremental costs and quality-adjusted life...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-019-00496-1
更新日期：2019-12-01 00:00:00
abstract：:Memokath-051 is a thermo-expandable, nickel-titanium alloy spiral stent used to treat ureteric obstruction resulting from malignant or benign strictures. The National Institute for Health and Care Excellence (NICE) selected Memokath-051 for evaluation. The company, PNN Medical, claimed Memokath-051 has clinical superi...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/s40258-018-0389-3
更新日期：2018-08-01 00:00:00
abstract：BACKGROUND:Immunization rates for human papillomavirus (HPV) infections remain low among teenagers despite strong evidence of the effectiveness of vaccines. Physician recommendations of the vaccine are far from universal. Several states have enacted policies that mandate HPV vaccination or distribute educational materi...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-016-0225-6
更新日期：2016-06-01 00:00:00
abstract：BACKGROUND:When pharmaceuticals are administered based on patient characteristics (for example weight or body surface area), an amount of product will be unused and must be disposed of. This wastage represents inefficiency and can distort decision making. METHODS:We present a method for the analysis of optimum fill vo...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-018-0444-0
更新日期：2019-06-01 00:00:00
abstract：:Economic models are developed to provide decision makers with information related to the real-world effectiveness of therapeutics, screening and diagnostic regimens. Although compliance with these regimens often has a significant impact on real-world clinical outcomes and costs, compliance and persistence have histori...
journal_title：Applied health economics and health policy
pub_type： 杂志文章,评审
doi：10.1007/BF03261872
更新日期：2012-11-01 00:00:00
abstract：:The mandatory nature of recommendations made by the National Institute for Health and Clinical Excellence (NICE) in the UK has highlighted inherent difficulties in the process of disinvestment in existing technologies to fund NICE-approved technologies. A lack of evidence on candidate technologies means that the proce...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/BF03256137
更新日期：2009-01-01 00:00:00
abstract：BACKGROUND:Pricing drugs in the California Workers' Compensation System (CAWCS) has become more difficult as there are increasingly fewer drugs listed in the Medi-Cal primary fee schedule, which is used as the source for CAWCS drug prices. This presents a challenge of providing timely and accurate CAWCS reimbursement. ...
journal_title：Applied health economics and health policy
pub_type： 杂志文章
doi：10.1007/s40258-018-0442-2
更新日期：2019-04-01 00:00:00
